Corticosteroid elimination in simultaneous liver–kidney transplantation recipients |
| |
| Authors: | Nicholas K. Weber Alexander C. Wiseman James F. Trotter |
| |
| Affiliation: | 1. Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, Aurora, CO, USA;2. Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Aurora, CO, USA and;3. Division of Gastroenterology and Hepatology, Baylor Health Care System, Dallas, TX, USA |
| |
| Abstract: | ![]()
Abstract: Background: Simultaneous liver–kidney transplantation (SLK) has more than doubled since 2002. While less common in kidney transplant alone recipients (KTA), corticosteroid discontinuation is performed routinely in liver transplantation, raising the question of optimal immunosuppression for SLK recipients. Methods: A retrospective case series of 16 SLK recipients under a steroid withdrawal protocol was performed to compare short‐term outcomes to a contemporaneous cohort of 32 KTA recipients. Results: In 69% of SLK recipients, corticosteroids were eliminated compared to 3% of KTA recipients, p < 0.0001. When comparing SLK and KTA recipients one yr post‐transplant, there were no significant differences in renal graft rejection (23.1% vs. 6.3%), death‐censored renal graft survival (100% vs. 97%), estimated glomerular filtration rate (74.4 vs. 62.6 mL/min), serum creatinine (1.10 vs. 1.39 mg/dL), or maintenance immunosuppression, respectively. Conclusions: Corticosteroids may be withdrawn safely in SLK recipients with one‐yr renal outcomes comparable to a KTA cohort. |
| |
| Keywords: | combined liver– kidney transplant immunosuppression kidney transplantation liver transplantation renal rejection rates |
|
|
